The Jewish PressGamida Cell has proprietary technology for growing the number and density of stem cells within a specific blood sample and seeks to enhance umbilical cord blood donations for implants to cure blood cancer in adults. Currently, umbilical cord blood can Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-CellJewish Business NewsGamida [ ]
http://blog.zandcell.com/novartis-trying-to-buy-israeli-stem-cell-research-developer-the-jewish-press/?utm_source=rss&utm_medium=rss&utm_campaign=novartis-trying-to-buy-israeli-stem-cell-research-developer-the-jewish-press
Inga kommentarer:
Skicka en kommentar